Laurence Anthony Seabra

Title: The Innovative Contributions of Laurence Anthony Seabra

Introduction

Laurence Anthony Seabra is a notable inventor based in Wirral, GB. He has made significant contributions to the field of cancer treatment and diagnosis, holding a total of 3 patents. His work focuses on developing methods that enhance the effectiveness of cancer therapies and improve diagnostic techniques.

Latest Patents

Seabra's latest patents include groundbreaking methods for treating cancer. One patent provides a method for screening effective agents for cancer treatment. This method involves selecting a putative agent that disrupts a function mediated by a critical normal gene product, which is essential for the survival of cancer cells but not for control cells. The process includes treating both cancer and control cell samples with the agent and determining its cytotoxic and growth inhibitory effects. An effective agent is identified as one that is more cytotoxic to cancer cells than to control cells. Another patent focuses on diagnosing cancerous or pre-cancerous states by testing for the co-elevation of CDK1 and CDK4 in cell samples. This patent also includes a diagnostic kit designed for this purpose.

Career Highlights

Seabra is associated with Theryte Limited, where he continues to advance his research and innovations in cancer treatment. His work has the potential to significantly impact the medical field, particularly in oncology.

Collaborations

Seabra has collaborated with notable colleagues, including Hilmar Meek Warenius and Philip Rudland. These partnerships have likely contributed to the development and refinement of his innovative methods.

Conclusion

Laurence Anthony Seabra's contributions to cancer treatment and diagnosis exemplify the importance of innovation in medical research. His patents reflect a commitment to improving patient outcomes through effective therapies and diagnostic tools.